Vimarsana
Biggest News Aggregation in the World

Page 3 - Aaron Ring News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Aaron Ring. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Aaron Ring Today - Breaking & Trending Today

Inspiring Collaboration in Cancer Research: The Mark Foundation for Cancer Research Announces 2022 Endeavor Award Recipients - Vimarsana News

Inspiring Collaboration in Cancer Research: The Mark Foundation for Cancer Research Announces 2022 Endeavor Award Recipients

/PRNewswire/ -- The Mark Foundation for Cancer Research has selected four outstanding scientific research projects to receive $12 million in funding for its...

Inspiring Collaboration in Cancer Research: The Mark Foundation for Cancer Research Announces 2022 Endeavor Award Recipients - Vimarsana News

Inspiring Collaboration in Cancer Research: The Mark Foundation for Cancer Research Announces 2022 Endeavor Award Recipients

/PRNewswire/ -- The Mark Foundation for Cancer Research has selected four outstanding scientific research projects to receive $12 million in funding for its...

Simcha Therapeutics Raises $40M in Series B Funding - Vimarsana News

Simcha Therapeutics Raises $40M in Series B Funding

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

What Causes Long COVID Is A Mystery. Here's How Scientists Are Trying To Crack It - Vimarsana News

What Causes Long COVID Is A Mystery. Here's How Scientists Are Trying To Crack It

It's not clear why some people who get COVID-19 are plagued with symptoms for many months after being infected, but scientists are investigating what's behind these "long haul" cases.

Source: ijpr.org
'Turncoat' antibodies are major culprits in severe COVID-19 - Vimarsana News

'Turncoat' antibodies are major culprits in severe COVID-19

Rogue antibodies are major culprits in severe cases of COVID-19, researchers report. These autoantibodies target and react with a person’s tissues or organs similar to ones that cause autoimmune diseases such as lupus or rheumatoid arthritis. In COVID-19 cases they can attack healthy tissue in brain, blood vessels, platelets, liver, and the gastrointestinal tract, researchers report. The more autoantibodies detected, the greater the disease severity patients experience. And the autoantibodies paradoxically also target and interfere with many immune system proteins that are designed to fend ...